REVOLUTIONISING RETINOL

Presenting the future of boosted retinol with iS Clinical

iS CLINICAL’s cosmeceutical portfolio expands this autumn, with a groundbreaking retinol innovation powered by two decades of scientific research.

The highly active, fast-acting Retinol+ Emulsion 0.3 and 1.0 are unique resurfacing formulae designed to deliver transformative results and elevate the patient’s skincare journey. Both products feature retinol derived from botanical sources, encapsulated within bio-identical lipids, ensuring effortless delivery to the skin while enhancing its resilience and long-term health.

More than just retinol, the duo offers a comprehensive solution to a myriad of skincare concerns. The proprietary blend of Bakuchiol, plus powerful botanical boosters, antioxidants, and Extremozymes® effectively targets fine lines, deep wrinkles, uneven skin tone, rough texture, and blemishes. Moreover, it enhances the complexion by smoothing, softening, and brightening, while promoting improved skin firmness and elasticity.

WHY IS CLINICAL?

In an era of positive ageing, the independent and privately owned brand has consistently led the way with pharmaceutical-grade botanical formulations clinically proven to support the journey of ageing well. Underpinned by rigorous scientific research, Retinol+ Emulsion 0.3 and 1.0 continue this tradition.

• Scientific Credibility:

The efficacy of Retinol+ Emulsion 0.3 and 1.0 is grounded in robust scientific research and iS CLINICAL’s commitment to evidence-based formulas. Gene activation studies, simulating at-home usage, demonstrated significant positive effects on skin gene expression processes, including wound healing, controlled apoptosis, antioxidant activity, skin homeostasis, and dermal-epidermal junction (DEJ) maintenance.

• Unique Botanical Blend

Both products feature a proprietary botanical blend including ascorbic acid, colloidal gold, and glutathione 0.5%. This stable and small-molecular vitamin C derivative penetrates the epidermis easily, aiding collagen production. Bakuchiol (1.0%), chlorella vulgaris extract, and lecithin (2.0%) synergistically enhance retinol’s performance, combating fine lines and hyperpigmentation. This blend is both keratolytic and antiinflammatory, preserving and enhancing skin health.

• Controlled Delivery System:

Retinol+ Emulsion 0.3 and 1.0 deliver an encapsulated stable retinol for controlled release, ensuring maximum efficacy while minimising potential irritation. This provides patients with the assurance of receiving the full benefits of retinol without compromising on comfort.

• Purity and Safety:

iS CLINICAL’s unwavering commitment to purity means Retinol+ Emulsion 0.3 and 1.0 are non-systemic and considered safe for use during pregnancy and nursing, aligning with a dedication to safe and effective treatment.

• Sustainably Integrated:

With the Retinol+ Emulsion 0.3 and 1.0 formulation, integrating into post-procedure regimens is easier than ever, enhancing client results and satisfaction.

THE PROFESSIONAL-STRENGTH ADVANTAGE

Distributed in the UK and Ireland by Harpar Grace International, iS CLINICAL’s commitment to in-clinic skincare solutions continues with Retinol+ Emulsion 1.0. This professional-strength formula serves as a catalyst for growth, boosting clinic sales, complementing in-clinic regimens, and attracting new patients.

Alana Chalmers, founder and chief executive officer of Harpar Grace International, remarks, “Backed by extensive research and expertise, Retinol+ Emulsion 0.3 and 1.0 are set to revolutionise the world of vitamin A and retinoid skin care. Backed by science and in-depth research, these formulas will establish a new standard for efficacy, safety, and results in the realm of cosmeceutical retinol skincare.”